1.75bn Citizens in the World’s Eight Richest Countries Remain Unconnected
A new study by the Wireless Broadband Alliance (WBA) reveals a staggering 1.75bn citizens in the world’s eight richest countries (by GDP) remain unconnected - with 34% residing in major urban centers. The report, launched today, highlights that the digital divide remains a global problem, despite the fact, that driving universal connectivity is a common priority for all countries.
The new study, undertaken by IHS Markit to mark World Wi-Fi Day, explores the levels of urban and rural connectivity across eight major countries: Brazil, China, Germany, India, Japan, Russia, the UK and the USA. It also uncovers the challenges faced and the initiatives being implemented by five of the world’s major cities: Delhi, London, Moscow, New York and Sao Paulo.
Key findings from the report reveal:
- Delhi and Sao Paulo have the largest number of unconnected citizens. 29% (5.331 million) of the population of Delhi are unconnected, 36% in Sao Paolo, (4.349 million) are unconnected
- London is the most connected city, with just 7% of citizens unconnected (625,336)
- 19% of people in New York City are unconnected (1.600 million), while 17% of people in Moscow are unconnected (2.154 million)
Total unconnected individuals (Million)
|Total unconnected individuals as % of total population|
|United States||North America||78.401||24.18|
Internet adoption has been faster in cities than in rural areas, however urban areas still face significant challenges to expanding internet users. These challenges include limited spending power, lack of availability of technology, lack of awareness of benefits gained from using the internet, and also, IT literacy levels.
In both developing and mature markets, availability of affordable internet services is still an obstacle to connectivity. Even among those countries with higher average salaries, the existence of economic and social divides significantly shapes the issue of the digital divide.
- In New York, one of the greatest barriers to connectivity is the quality and affordability of internet connections
- For Londoners, IT skills and an understanding of the benefits provided by being connected are, along with spending power, key challenges to internet adoption
- Moscow has faced specific challenges related to infrastructure, developing an integrated approach to promoting internet adoption, and ensuring a high standard and quality of internet services.
The report also highlights the many benefits and opportunities unconnected individuals miss out, from generating savings to personal development as a result of not having access to information and education services. What’s more, digital inclusion is an engine for economic growth for cities, nations, and businesses of all sizes as it helps to attract investment, start new companies and stimulate innovation.
“Connectivity is now an essential commodity, much in the same category as power and water. Yet many people in some of the world’s major cities are still without an internet connection,” said Shrikant Shenwai, CEO of the WBA. “Wi-Fi is playing an instrumental role in helping cities bring wider and more affordable connectivity to its citizens. The WBA is committed to helping cities bridge the digital divide through initiatives like World Wi-Fi Day and our Connected City Advisory Board, and see Wi-Fi as key to bringing connectivity to everyone, everywhere.”
“The issue of the urban unconnected is of critical importance the economies and societies around the world. We call on Governments around the world to re-double their focus on connecting the urban unconnected. It’s vital that internet access becomes recognized as a human right, and that all stakeholders involved in the provision of broadband work together to make this happen,” added Shenwai.
World Wi-Fi Day was launched by the WBA in 2016 to help accelerate the deployment of affordable connectivity globally. The initiative encourages cities and government bodies, as well as operators, service providers, technology vendors and internet giants, to come together to deliver connectivity to everyone, everywhere.
About the Wireless Broadband Alliance
Founded in 2003, the mission of the Wireless Broadband Alliance (WBA) is to accelerate global leadership for enabling of wireless services that are seamless, secure and interoperable. Building on our heritage of Next Generation Hotspot (NGH) and carrier Wi-Fi, WBA will continue to drive and support the adoption of Next Generation Wireless services across the entire public Wi-Fi ecosystem, including IoT, Converged Services, Smart Cities, 5G, etc. Today, membership includes major fixed operators such as BT, Comcast and Charter Communications; seven of the top 10 mobile operator groups (by revenue) and leading technology companies such as Cisco, Microsoft, Huawei Technologies, Google and Intel.
The WBA Board includes AT&T, Boingo Wireless, BT, China Telecom, Cisco Systems, Comcast, Intel, KT Corporation, Liberty Global, NTT DOCOMO, Orange and Ruckus Wireless. For a complete list of current WBA members, please click here.
Follow Wireless Broadband Alliance at:
The white paper is the result of the research conducted on the topic of the digital divide and urban unconnected across eight leading countries (Brazil, China, Germany, India, Japan, Russia, the United Kingdom, and the United States of America) with deep dive studies provided for five global cities.
The research was carried out through primary and secondary research and was complemented by interviews with city authorities and experts on the issue of digital divide and connectivity.
For the purpose of this report an unconnected individual is defined as an individual who does not have access to or cannot afford broadband connectivity. Sources used for this white paper include, among others, national statistical offices, city statistical offices, national telecoms regulators, city departments websites, internet usage or adoption surveys, IHS Markit proprietary data, and other sources such as the International Telecoms Union (ITU), the United Nation, and the World Bank.
+44 203 824 9200
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Andersen Global Expands Presence in Germany with Addition of Thierhoff Müller & Partner13.12.2017 08:01 | Pressemelding
Andersen Global is proud to announce an expanded presence in Germany as Thierhoff Müller & Partner, a tax and legal firm with offices in Leipzig and Frankfurt, combines its practice with Andersen Tax & Legal in Germany. Through its German member firms, Andersen Tax & Legal and Alegis Steuerberatungsgesellschaft mbH, Andersen Global now has more than 65 professionals focused on providing tax and legal services and business advice across five locations in Germany, including Cologne, Dusseldorf, and Merzig. “Thierhoff Müller is highly regarded in complex restructuring matters. Together with our existing legal and tax practice, we will be able to increase our service offerings for our clients,” said Stefan Kraus, Managing Partner of Andersen Tax & Legal in Germany. “We are dedicated to providing outstanding service and are adding additional competencies in tax and legal such as corporate r
Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs13.12.2017 08:00 | Pressemelding
Aprecia Pharmaceuticals, LLC (“Aprecia”), The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals, Ltd. (“Cycle”) today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration. Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s
Group Vivendi Africa Deploys Netcracker OSS to Enhance Service Management as it Expands Across the Continent12.12.2017 16:07 | Pressemelding
Netcracker Technology announced today that its OSS suite was selected and deployed to support the long-term growth strategy of Group Vivendi Africa (GVA). GVA is a newly formed affiliate of the French-based multinational conglomerate Vivendi with the goal to deploy and operate a fiber network across Africa. Netcracker's OSS will be used as a consolidated solution to identify service availability across GVA's operating countries and then fulfill and provision those services to customers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005937/en/ Netcracker's highly productized, out-of-the-box applications enabled the OSS suite to be deployed in seven months, meeting GVA's demand to leverage an integrated service fulfillment and inventory solution that could satisfy its long-term growth expectations, as well as s
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 15:23 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00 | Pressemelding
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33 | Pressemelding
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom